Med

Med is a comprehensive medical flagship journal under Cell Press, focusing on publishing clinical and translational research. Since its establishment at the end of 2020, this journal has become an important part of the medical research community, particularly playing a positive role in promoting the translation of laboratory results into clinical practice. The editorial team of the magazine is committed to publishing evidence-based transformative scientific research that can provide new insights into disease cognition and accelerate the process of medical improvement.

The characteristic of a journal lies in its interdisciplinary collaboration model, which unites academia, clinical doctors, biotechnology and pharmaceutical companies, as well as policy researchers, to jointly promote the development of medical research. Its articles typically include informative "background and significance" paragraphs, as well as a clear "Clinical and Translational (CAT)" schedule that displays the stage of research in the clinical translation interval.

《医学》是Cell Press出版社旗下的综合性医学旗舰期刊，专注于发表临床和转化研究。该期刊自2020年底创刊以来，已经成为医学研究社区的重要组成部分，特别是在推动实验室成果向临床转化方面发挥了积极作用。杂志的编辑团队致力于发表实证为基础的变革性科学研究，这些研究能够为疾病认知提供新的见解，并加速医疗改进进程。

期刊的特点在于其跨学科的合作模式，它团结了学术界、临床医生、生物科技和制药公司以及政策研究人员，共同推进医学研究的发展。它的文章通常包含科普性质的“背景和意义”段落，以及清晰展示研究在临床转化区间所处阶段的“临床和转化（Clinical and Translational，CAT）”进度表。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映MEDICINE, RESEARCH & EXPERIMENTAL领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为12.8，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。